Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
PaperCitations, authors & open-access status
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 11 citations, 2025 year and closed oa status.
11
Citations
2025
Year
closed
OA Status